Equillium (EQ) Times Interest Earned (2018 - 2023)
Equillium (EQ) reported Times Interest Earned of -$13.86 for Q2 2023, up 73.5% year-over-year from -$7.99 in Q2 2022, and up 21.7% quarter-over-quarter from -$17.71 in Q1 2023.
Equillium (EQ) Times Interest Earned (2018 - 2023) Analysis & Trends
Equillium (EQ) has 6 years of Times Interest Earned data on file, last reported at -$13.86 in Q2 2023.
- Times Interest Earned for Q2 2023 came in at -$13.86, up 73.5% year-over-year; the trailing twelve-month figure through Mar 2024 was -$50.98 (down 81.82% YoY), and the FY2023 annual result was -$29.58, up 49.83% from the prior year.
- Times Interest Earned grew to -$13.86 in Q2 2023 per EQ's latest filing, from -$17.71 in the prior quarter.
- Over five years, Times Interest Earned peaked at $7.54 in Q4 2022 and troughed at -$3162.0 in Q3 2019.
- A 5-year average of -$231.89 and a median of -$32.29 in 2020 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2019 and 2022: Times Interest Earned plunged 173341.24% in 2019, then surged 119.3% in 2022.
- A 5-year view of Times Interest Earned shows it stood at -$27.49 in 2019, then decreased by 18.21% to -$32.5 in 2020, then fell by 20.15% to -$39.05 in 2021, then surged by 119.3% to $7.54 in 2022, then slumped by 284.0% to -$13.86 in 2023.
- Business Quant data shows EQ's Times Interest Earned at -$13.86 in Q2 2023, -$17.71 in Q1 2023, and $7.54 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -13.86 |
| Mar 31, 2023 | -17.71 |
| Dec 31, 2022 | 7.54 |
| Sep 30, 2022 | -49.58 |
| Jun 30, 2022 | -52.32 |
| Mar 31, 2022 | -146.39 |
| Dec 31, 2021 | -39.05 |
| Sep 30, 2021 | -37.07 |
| Jun 30, 2021 | -32.75 |
| Mar 31, 2021 | -32.08 |
| Dec 31, 2020 | -32.50 |
| Sep 30, 2020 | -23.61 |
| Jun 30, 2020 | -24.12 |
| Mar 31, 2020 | -27.30 |
| Dec 31, 2019 | -27.49 |
| Sep 30, 2019 | -3,162.00 |
| Dec 31, 2018 | -18.46 |
| Sep 30, 2018 | -1.82 |
| Jun 30, 2018 | -1.82 |
| Mar 31, 2018 | -2.12 |